Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market. According to the latest research from Future Market Insights, the global bone growth stimulators market is expected to account for $1.38 billion by the end of 2029. The bone growth stimulators market is estimated to grow at a compound annual growth rate of 5.2 percent through the forecast period 2019-2029. However, factors such as the high prices of devices and product recalls are expected to hamper the growth of the bone growth stimulators market.
Over the past decades, spending on healthcare has grown globally. The growth of the emerging markets and increasing geriatric population in developed economies are among factors expected to boost healthcare spending, which is expected to subsequently expand the bone growth stimulators market. Increasing healthcare spending is expected to boost the demand for bone growth stimulators, which is, in turn, predicted to create high growth opportunities for players in the bone growth stimulators market over the forecast period.
Furthermore, the increasing number of fractures and technological advancements have increased non-invasive, and rapid technologies in the healthcare industry, which is boosting the bone growth stimulators market. Moreover, manufacturers are undertaking various efforts to provide bone growth stimulators that are more versatile and more convenient for patient use. According to the World Bank, around 1.25 million people get injured in road accidents, which leads to fractures and the requirement of fusion surgeries for their treatment every year. These are some of the prime factors that are expected to drive the global Bone growth stimulators market over the forecast period 2019-2029.
The North America bone growth stimulators market and Europe bone growth stimulators market combined are expected to hold a share of approximately 65 percent of the global bone growth stimulators market during the forecast period. This can be mainly attributed to the high adoption of advanced technology and reduced hospital visits.
Based on the product type, the global bone growth stimulators market has been segmented broadly into non-invasive bone growth stimulators and invasive bone growth stimulators. Non-invasive bone growth stimulators are also segmented into various other sub-segments such as capacitive coupling (CC) devices, pulsed electromagnetic field (PEMF) devices, combined magnetic field (CMF) devices, and ultrasound bone growth stimulators. The non-invasive bone growth stimulators segment is expected to hold a prominent share of the global bone growth stimulators market.
Based on applications, the bone growth stimulators market has been segmented into trauma injury and fractures, spinal fusion surgeries, and osteogenesis. In terms of revenue, the trauma injury and fractures segment dominated the global bone growth stimulators market in 2018. Based on the end user, the bone growth stimulators market is segmented into hospitals, homecare settings, orthopedic clinics, and ambulatory surgical centres. The hospitals segment held the maximum share of the bone growth stimulators market in 2018, and is predicted to continue to dominate the market throughout the forecast period.
Some of the key players operating in the bone growth stimulators market are Zimmer Biomet Holdings Inc., Bioventus LLC, DJO Global, Orthofix Holdings Inc., Ossatec Benelux Ltd., IGEA, and Ito Co., Ltd.
Future Market Insights provides market intelligence and consulting services, serving clients in more than 150 countries. FMI is headquartered in London and has delivery centers in the United States and India.